Feature

Article

Pharmaceutical Executive

Pharmaceutical Executive: July/August 2024
Volume44
Issue 7/8

Pharmaceutical Executive: July/August 2024 Issue (PDF)

Click the title above for a link to open the Pharmaceutical Executive July/August 2024 issue in an interactive PDF format.

July/August 2024
Download Issue PDF
Articles in this issue
Pharmaceutical Executive: July/August 2024 Issue (PDF)
Pharmaceutical Executive: July/August 2024 Issue (PDF)
An AI Pulse Check
An AI Pulse Check
Divergent Paths: Pharm Exec Profiles Five Recent Drug Launches
Divergent Paths: Pharm Exec Profiles Five Recent Drug Launches
A Promising Option: Exxua
A Promising Option: Exxua
Opening the Door: Omvoh
Opening the Door: Omvoh
'Marked’ for Stardom?: Truqap
'Marked’ for Stardom?: Truqap

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Helen Sabzevari
Pharmaceutical Executive
Helen Sabzevari
Related Content
Stock.adobe.com
September 12th 2025

White House Officials Drafting Executive Order Enforcing Harsh Restrictions on Treatments Discovered in China: Report

Nicholas Jacobus
Pharmaceutical Executive
September 12th 2025

Pharmaceutical Executive Daily: September 11, 2025

Nicholas Jacobus
Stock.adobe.com
September 12th 2025

Intercept Pharmaceuticals Withdraws Ocaliva from Shelves Following U.S. Regulator’s Request

Nicholas Jacobus
Pharmaceutical Executive
September 12th 2025

Pharmaceutical Executive Daily: September 9, 2025

Nicholas Jacobus
Pharm Exec MFN webinar
September 12th 2025

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients

Mike Hollan
David Bell
September 12th 2025

The Strategies Behind Bringing a Novel Therapy to Market Successfully

David Bell
© 2025 MJH Life Sciences

All rights reserved.